[pending] MED NAP BENZALKONIUM CHLORIDE ANTISEPTIC (BENZALKONIUM CHLORIDE)
Pending LLM rewrite. Source: FDA_DRUG D-0366-2026.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: Pending LLM scoring against the rubric.
Plain-English summary
CGMP Deviations
The recalled product
- Product
- MED NAP BENZALKONIUM CHLORIDE ANTISEPTIC (BENZALKONIUM CHLORIDE)
- Brand
- MED NAP BENZALKONIUM CHLORIDE ANTISEPTIC
- Manufacturer
- ACME UNITED CORPORATION
- Category
- Drug — Drugs
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (20)
- Lot #: MN09322
- Exp. Date Mar 2027
- MN15222
- Exp. Date May 2027
- MN21622
- Exp. Date Jul 2027
- MN31822
- Exp. Date Oct 2027
- MN06223
- MN06323
- Exp. Date Feb 2028
- MN12523
- Exp. Date Apr 2028
- MN16123
- Exp. Date May 2028
- MN20523
- MN20623
- MN20723
- Exp. Date Jun 2028
- MN23223
UPCs (1)
- 0092265940061
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- SevereAtomoxetine Capsules Recalled Due to Labeling Mix-Up Error
FDA (Drugs) · 2026-05-27
- ModeratePrimidone Tablets Recalled Due to API Cross-Contamination
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- SevereErythromycin Tablets Recalled for Impurity Above Acceptable Limits
FDA (Drugs) · 2026-05-27